Home › NDC Lookup › Ingredients › Polyvinyl Alcohol And Povidone And Tetra... › 70000-0087-01
Eyes Irritation Relief Polyvinyl Alcohol and Povidone and Tetrahydrozoline Hydrochloride 5 mg/mL; 6 mg/mL; .5 mg/mL Liquid — NDC 70000-0087-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Eyes Irritation Relief Polyvinyl Alcohol and Povidone and Tetrahydrozoline Hydrochloride 5 mg/mL; 6 mg/mL; .5 mg/mL Liquid — NDC 70000-0087-1 (Billing 70000-0087-01)

by CARDINAL HEALTH 110, LLC. DBA LEADER · 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER

This is a package of Eyes Irritation Relief Polyvinyl Alcohol and Povidone and Tetrahydrozoline Hydrochloride 5 mg/mL; 6 mg/mL; .5 mg/mL Liquid from CARDINAL HEALTH 110, LLC. DBA LEADER, marketed since Mar 2021 and currently FDA-listed, this package's marketing is listed to end Nov 2026. It is this product's only package size.

NDC 70000-0087-01
🏷️ FDA NDC (as labeled) 70000-0087-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70000-0087-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
70000 labeler · 0087 product · 1 package
Package marketed since
Mar 9, 2021
Package marketing ended
Nov 30, 2026
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 7000000871 0
FDA record last changed
Jul 24, 2026
🚨
Active recall for this product.
Class I · Nov 13, 2023 — Non-Sterility (Kilitch Healthcare India Limited) · FDA recall D-0297-2024
Lots / codes: All lots · reported Feb 14, 2024
Class I · Oct 31, 2023 — Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility. (Cardinal Health Inc.) · FDA recall D-0131-2024
Lots / codes: ALL LOTS · reported Nov 29, 2023
Check your lot/expiration against the official notice — look up the recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0087-1
Product NDC 70000-0087
11-digit billing NDC 70000008701
NCPDP billing unit ML — per mL (volume)
RxCUI 1235569
UNII 532B59J990, FZ989GH94E, 0YZT43HS7D
Application # M018
SPL Set ID bd2608c6-ffdf-352a-e053-2995a90a26a8
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-03-09
Marketing end 2026-11-30
Route OPHTHALMIC
Dosage form LIQUID
Substance POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE, UNSPECIFIED; TETRAHYDROZOLINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86409903752020
GPI class Eye Irritation Relief
GCN Seq No 064168
GCN 99874
HICL code 035694
Ingredient (HICL) Tetrahydrozoline/Polyvin A/Pov
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6D
Therapeutic class — specific (HIC3) Eye Vasoconstrictors (Otc Only)
AHFS code 52:32.00.00
AHFS class Vasoconstrictors
FDB label name EYE IRRITATION RELIEF DROPS
FDB brand name Eye Irritation Relief
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 064168
  • GCN: 99874
  • GPI-14 (Medi-Span): 86409903752020
  • HICL (First Databank): 035694
  • AHFS class code: 52:32.00.00
  • RxCUI (RxNorm): 1235569
Why two NDCs? The FDA registers this code as 70000-0087-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0087-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Sympathomimetics, plain class.

Drug family (ATC) Sympathomimetics, plain, Sympathomimetics used as decongestants
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name EYE IRRITATION RELIEF DROPS Ingredient Tetrahydrozoline/Polyvin A/Pov
📖 About the active ingredient MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.

Ophthalmic tetrahydrozoline is used to relieve minor eye irritation and redness caused by colds, pollen, and swimming.

Read the full MedlinePlus article ↗
🧪 What is this product?

This is an over-the-counter eye drop liquid marketed under FDA monograph rules for eye irritation relief. It contains polyvinyl alcohol and povidone, which are lubricating agents typically used to coat and moisturize the eye surface, along with tetrahydrozoline hydrochloride, a decongestant commonly used to reduce redness and swelling in the eyes. The product is designed for topical application directly to the eye.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0087-01 You're viewing this Main listing 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER 2021-03-09 Nov 30, 2026 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Multi-Action Relief 5 mg/mL; 6 mg/mL; .5 mg/mL 59390-0156-13 Altaire 1 bottle — — FDA listed —
Clear Eyes Triple Relief 5 mg/mL; 6 mg/mL; .5 mg/mL 67172-0898-01 Prestige 1 bottle — — FDA listed —
Eyes Irritation Relief 5 mg/mL; 6 mg/mL; .5 mg/mLthis 70000-0087-01 CARDINAL 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Mar 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII F5UM2KM3W7
    Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII 660YQ98I10
    Potassium chloride is a mineral salt used in medicines as a buffer and to help maintain the proper pH balance and stability of the formulation during storage and use.
  • UNII 1Q73Q2JULR
    Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 22ADO53M6F
    A mineral salt derived from phosphoric acid, used as a buffer to maintain the pH balance of the medication and help stabilize the active ingredients.
  • UNII 5QWK665956
    A salt derived from phosphoric acid and sodium, used primarily as a buffer to control the acidity or pH of a medication, helping keep it stable during storage and use.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesBenzalkonium Chloride,  Disodium Hydrogen Phosphate Anhydrous, Disodium Edetate, Mannitol, Potassium Chloride, Purified Water, Sodium dihydrogen Phosphate Dihydrate, Sodium Chloride, Sodium Citrate, May Contain Hydrochloric Acid and/or Sodium Hydroxide to Adjust PH.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCARDINAL HEALTH 110, LLC. DBA LEADER
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedMar 2021
Product typeHuman Otc Drug
Portfolio163 products on file

More NDCs from CARDINAL HEALTH 110, LLC. DBA LEADER labeler code 70000

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 43 words ▾

Uses ▪ for the temporary relief of burning & irritation due to dryness of the eye ▪ for use as a protectant against further irritation or to relieve dryness of the eye ▪ relieves redness of the eye due to minor eye irritations

⏱️ Dosage and Administration 15 words ▾

Directions Instill 1 to 2 drops in the affected eye(s) up to four times daily.

⚠️ Warnings 120 words ▾

Warnings For external use only Do not use if solution changes color or becomes cloudy. Ask a doctor before use if you have narrow angle glaucoma. When using this product ▪ to avoid contamination, do not touch tip to any surface ▪ replace cap after using ▪ overuse may produce increased redness of the eye ▪ pupils may become enlarged temporarily Stop use & ask a doctor if ▪ you experience eye pain ▪ you experience changes in vision ▪ you experience continued redness or irritation of the eye ▪ the condition worsens ▪ symptoms last for more than 72 hours Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center(1-800-222-1222) right away.

🧪 Active Ingredient 14 words ▾

Active ingredients Polyvinyl alcohol 0.5%

Active ingredients Povidone 0.6%

Active ingredient Tetrahydrozoline hydrochloride 0.05%

🧪 Inactive Ingredients 35 words ▾

Inactive ingredients Benzalkonium Chloride, Disodium Hydrogen Phosphate Anhydrous, Disodium Edetate, Mannitol , Potassium Chloride, Purified Water, Sodium dihydrogen Phosphate Dihydrate, Sodium Chloride, Sodium Citrate , May Contain Hydrochloric Acid and/or Sodium Hydroxide to Adjust PH.

🎯 Purpose 5 words ▾

Purpose Lubricant

Purpose Redness reliever

📄 Do Not Use 10 words ▾

Do not use if solution changes color or becomes cloudy.

📄 Ask a Doctor Before Use If 11 words ▾

Ask a doctor before use if you have narrow angle glaucoma.

📄 When Using This Product 35 words ▾

When using this product ▪ to avoid contamination, do not touch tip to any surface ▪ replace cap after using ▪ overuse may produce increased redness of the eye ▪ pupils may become enlarged temporarily

📄 Stop Use and Ask a Doctor If 40 words ▾

Stop use & ask a doctor if ▪ you experience eye pain ▪ you experience changes in vision ▪ you experience continued redness or irritation of the eye ▪ the condition worsens ▪ symptoms last for more than 72 hours

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center(1-800-222-1222) right away.

📄 Package Label / Principal Display Panel 101 words ▾

Principal Display Panel LEADER™ NDC 70000-0087-1 Sterile / Triple Action Eye Irritation Relief Polyvinyl Alcohol / Povidone Tetrahydrozoline Hydrochloride Lubricant / Redness Reliever • Relieves Irritation and Redness • Moisturizes

0.5FL OZ (15 mL) 0.5% / 0.6% / 0.05% bottle label

Principal Display Panel LEADER™ NDC 70000-0087-1 Sterile / Triple Action Eye Irritation Relief Polyvinyl Alcohol / Povidone Tetrahydrozoline Hydrochloride Lubricant / Redness Reliever • Relieves Irritation and Redness • Moisturizes Actual Bottle Size on Side Panel COMPARE TO CLEAR EYES® TRIPLE ACTION active ingredients* 100% Money Back Guarantee

0.5FL OZ (15 mL) 0.5% / 0.6% / 0.05% carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but CARDINAL HEALTH 110, LLC. DBA LEADER has reported a marketing end date of 2026-11-30, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
CARDINAL HEALTH 110, LLC. DBA LEADER is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70000-0084-01 · CARDINAL 70000-0088-01 · CARDINAL →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.